Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent

Clinical trial NCT00334945 · COMPLETED

Trial details

NCT number: NCT00334945
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Study type: OBSERVATIONAL

Growth Disorders

Start date: 2006-04-01
Primary completion: 2010-06-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.